These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6293899

  • 1. Responsiveness of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus.
    Beretta-Piccoli C, Weidmann P, Fraser R.
    Diabetes; 1983 Jan; 32(1):1-5. PubMed ID: 6293899
    [Abstract] [Full Text] [Related]

  • 2. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.
    Iwasaki R, Kigoshi T, Uchida K, Morimoto S.
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):83-9. PubMed ID: 2545066
    [Abstract] [Full Text] [Related]

  • 3. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
    Kigoshi T, Iwasaki R, Kaneko M, Nakano S, Azukizawa S, Uchida K, Morimoto S.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
    [Abstract] [Full Text] [Related]

  • 4. Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism.
    Kigoshi T, Morimoto S, Uchida K, Hosojima H, Yamamoto I, Imaizumi N, Azukizawa S.
    J Lab Clin Med; 1985 Feb; 105(2):195-200. PubMed ID: 2982980
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H, Lorenz R, von Werder K, Weber PC.
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [Abstract] [Full Text] [Related]

  • 12. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension.
    Semple PF, Mason PA, Fraser R.
    Clin Endocrinol (Oxf); 1980 May; 12(5):473-81. PubMed ID: 7428185
    [Abstract] [Full Text] [Related]

  • 13. Time course of plasma corticosterone, 18-hydroxycorticosterone and aldosterone concentrations following CRF administration in the rat. A phase of corticosterone inhibition.
    Maser-Gluth C, Toygar A, Vecsei P.
    Life Sci; 1984 Aug 20; 35(8):879-84. PubMed ID: 6090854
    [Abstract] [Full Text] [Related]

  • 14. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.
    Oelkers W, Boelke T, Bähr V.
    J Clin Endocrinol Metab; 1988 Jan 20; 66(1):181-6. PubMed ID: 2826525
    [Abstract] [Full Text] [Related]

  • 15. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone secretion.
    Maser-Gluth C, Toygar A, Schaz K, Vecsei P.
    Clin Exp Hypertens A; 1984 Jan 20; 6(10-11):2097-100. PubMed ID: 6099779
    [Abstract] [Full Text] [Related]

  • 16. Dopamine affects angiotensin II-induced steroidogenesis by altering clearance of the peptide in man.
    Connell JM, Tonolo G, Davies DL, Finlayson J, Ball SG, Inglis G, Fraser R.
    J Endocrinol; 1987 Apr 20; 113(1):139-46. PubMed ID: 3585223
    [Abstract] [Full Text] [Related]

  • 17. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
    Guthrie GP.
    J Lab Clin Med; 1981 Sep 20; 98(3):364-73. PubMed ID: 6267148
    [Abstract] [Full Text] [Related]

  • 18. Hypermineralocorticoidism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II.
    Isles CG, MacDougall IC, Lever AF, Fraser R.
    Clin Endocrinol (Oxf); 1987 Feb 20; 26(2):239-51. PubMed ID: 2822295
    [Abstract] [Full Text] [Related]

  • 19. The interaction of ACTH and angiotensin II in the control of corticosteroid plasma concentration in man.
    Mason PA, Fraser R, Semple PF, Morton JJ.
    J Steroid Biochem; 1979 Feb 20; 10(2):235-9. PubMed ID: 229349
    [No Abstract] [Full Text] [Related]

  • 20. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
    Miyamori I, Yasuhara S, Matsubara T, Okamoto S, Ikeda M, Koshida H, Morise T, Takeda Y, Takeda R, Vecsei P.
    Endocrinol Jpn; 1987 Dec 20; 34(6):809-19. PubMed ID: 2836182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.